Nalaganje...

Inhibition of Wee1 sensitizes cancer cells to anti-metabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality

Inhibition of Wee1 is emerging as a novel therapeutic strategy for cancer, and some data suggest that cells with dysfunctional p53 are more sensitive to Wee1 inhibition combined with conventional chemotherapy than those with functional p53. We and others found that Wee1 inhibition sensitizes leukemi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Linden, Annemie A. Van, Baturin, Dmitry, Ford, James B., Fosmire, Susan P., Gardner, Lori, Korch, Christopher, Reigan, Philip, Porter, Christopher C.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897395/
https://ncbi.nlm.nih.gov/pubmed/24121103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0424
Oznake: Označite
Brez oznak, prvi označite!